Orange Psychopharmacology Center is categorized under Internal Medicine Doctors in Goshen, NY and active since 2010.
Orange Psychopharmacology Center was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Lisa Wellman at the company’s single location by writing to 3 Coates Drive # 8, Goshen, New York NY 10924 or by phoning (845) 291-0999. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orange Psychopharmacology Center |
| Contact Person: | Lisa Wellman |
| Address: | 3 Coates Drive # 8, Goshen, New York 10924 |
| Phone Number: | (845) 291-0999 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Orange Psychopharmacology Center was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Lisa Wellman for inquiries that concern Orange Psychopharmacology Center by calling the company number (845) 291-0999, as your correspondence is most welcome. Additionally, the physical location of the single location of Orange Psychopharmacology Center can be found at the coordinates 41.390463,-74.338133 as well as the street address 3 Coates Drive # 8 in Goshen, New York 10924.
For its online presence, you may visit Orange Psychopharmacology Center’s website at and engage with its social media outlets through on Twitter and on Facebook.